Precigen (PGEN) EBITDA Margin (QoQ) (2012 - 2026)
Powered by 
Analysis
Precigen (PGEN) EBITDA Margin (QoQ) (2012 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Krystal Biotech | 10.27 Bn | 9.43 Bn | 112.79 Mn |
| 2 | CRISPR Therapeutics AG | 5.17 Bn | 5.17 Bn | - |
| 3 | Iovance Biotherapeutics | 3.79 Bn | 3.49 Bn | 55.72 Mn |
| 4 | Legend Biotech | 3.68 Bn | 2.71 Bn | 251.50 Mn |
| 5 | uniQure | 3.05 Bn | 3.05 Bn | 5.49 Mn |
| 6 | Beam Therapeutics | 2.65 Bn | 2.65 Bn | - |
| 7 | Precigen | 2.44 Bn | 2.44 Bn | 52.17 Mn |
| 8 | Sarepta Therapeutics | 2.33 Bn | 1.53 Bn | 251.87 Mn |
| 9 | Vericel | 1.99 Bn | 1.83 Bn | 56.40 Mn |
| 10 | Taysha Gene Therapies | 1.97 Bn | 1.97 Bn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 6,696.00 |
| Mar 31, 2026 | 44,883.00 |
| Dec 31, 2025 | 70,544.00 |
| Sep 30, 2025 | 253,070.00 |
| Jun 30, 2025 | -202,574.00 |
| Mar 31, 2025 | 71,129.00 |
| Dec 31, 2024 | -16,524.00 |
| Sep 30, 2024 | 625,444.00 |
| Jun 30, 2024 | -619,348.00 |
| Mar 31, 2024 | 49,495.00 |
| Dec 31, 2023 | -126,870.00 |
| Sep 30, 2023 | -32,303.00 |
| Jun 30, 2023 | 7,315.00 |
| Mar 31, 2023 | -3,204.00 |
| Dec 31, 2022 | -119,083.00 |
| Sep 30, 2022 | 78,449.00 |
| Jun 30, 2022 | -42,819.00 |
| Mar 31, 2022 | 19,187.00 |
| Dec 31, 2021 | 5,226.00 |
| Sep 30, 2021 | 4,122.00 |